Sponsors

Event Co-HostsReception SponsorGold SponsorSilverEvent SponsorRegistration & LanyardPlatinum Event PartnerEvent Partners

Life Sciences Conferences

The Burrill Personalized Medicine Meeting

Agenda

Day One

7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 9:15 a.m.
Welcome and Personalized Medicine Industry Update
G. Steven Burrill, CEO, Burrill & Company

9:15 – 10:00 a.m.
Fireside Chat: The Future of Personalized Medicine/ Precision Medicine
Kathryn Philips, Professor of Health Economics and Health Services Research, University of California, San Francisco and Founder/Director of the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS)
George Poste, Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor and Del E. Webb Chair in Health Innovation, Arizona State University
Discussion with: G. Steven Burrill, CEO, Burrill & Company

10:00 – 10:30 a.m.
Break

10:30 – 11:10 a.m.
Panel: Are Medical Schools Preparing Doctors for Genomic Medicine?
Panelists:
Catherine Lucey, MD, Vice Dean for Education, UCSF School of Medicine
Keyan Salari, MD, PhD, Massachusetts General Hospital and Harvard Medical School
Shweta Dhar, MD, FACMG, Director, Adult Genetics, Baylor College of Medicine
Moderator: Ann Hanham, Managing Director, Burrill & Company

11:10 a.m. – 12:00 p.m.
Fireside Chat: Personalized Medicine Reshapes Big Pharma R&D
Bernard Munos, Fellow, FasterCures and Founder, InnoThink
Discussion with: G. Steven Burrill, CEO, Burrill & Company

12:00 – 1:00 p.m.
‘Conversations with Experts’ Luncheon

1:00 – 1:40 p.m.
Keynote: Where is Personalized Medicine Taking Us?
Randy Scott, CEO, InVitae
Introduced by: G. Steven Burrill, CEO, Burrill & Company

1:40 – 2:20 p.m.
Panel: The Genome Moves to the Clinic
Panelists:
Cliff Reid, CEO, Complete Genomics
Adina Mangubat, CEO Spiral Genetics
Paul Trevithick, CTO & COO, PanGenX
Moderator: Jonathan Hirsch, Founder & President, Syapse

2:20 – 3:00 p.m.
Are Patients Ready to Take Responsibility for Their Own Health?
Panelists:
Ari Tulla, CEO & Founder, BetterDoctor
Patricia Knight, Founder, Pacific Coast Health Advocacy LLC
Moderator: Daniel Kraft, Executive Director, FutureMed

3:00 – 3:20 p.m.
Break

3:20 – 4:00 p.m.
Keynote: Are Payers Ready to Squeeze Pricing on Personalized Medicine?
Roger Longman, CEO, Real Endpoints
Introduced by: G. Steven Burrill, CEO, Burrill & Company

4:00 – 4:40 p.m.
Presentation: Duke Study
Paul Goldberg, Editor and Publisher, The Cancer Letter
Introduced by: G. Steven Burrill, CEO, Burrill & Company

4:40 – 5:20 p.m.
Panel: Beyond Cancer –Personalized Medicine’s Push into New Disease Areas
Panelists:
Neil K. Warma, President & CEO, Director, Opexa Therapeutics
William Hagstrom, President and CEO, Crescendo Biosciences
David W. Martin, CEO, AvidBiotics Corp.
Moderator: George Poste, DVM, PhD, Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor and Del E. Webb Chair in Health Innovation, Arizona State University

5:20 p.m.
Meeting Wrap-Up (Day One)
G. Steven Burrill, CEO, Burrill & Company

5:30 – 7:30 p.m.
Networking Reception
Sponsored by: Invest in Denmark

Day Two

7:30 – 8:30 a.m.
Breakfast

8:30 – 9:10 a.m.
Panel: Understanding the Recent Supreme Court Rulings on Patents and Patent Strategies for the Future
Panelists:
Pauline Farmer-Koppenol, Associate, Fenwick & West
Antoinette F. Konski, Partner, Foley & Lardner, LLP
Moderator: Tamara Fraizer, PhD, Principal, Fish & Richardson

9:10 – 9:50 a.m.
Keynote: “Beyond GINA - Ethical and Legal Concernsin the Age of the Genome”
Hank Greely, the Deane F. and Kate Edelman Johnson Professor of Law and professor (by courtesy) of genetics at Stanford University; Director of the Stanford Center for Law and the Biosciences, and Chair of the Steering Committee of the Stanford Center for Biomedical Ethics
Introduced by: G. Steven Burrill, CEO, Burrill & Company

9:50 – 10:30 a.m.
Panel: Can Big Data Change Medical Practice?
Panelists:
Colin Hill, CEO, President, Chairman & Co-Founder, GNS Healthcare
Vijay Chandru, CEO, Strand Life Sciences
Mads Melbye, MD, DMSc, Head of Division of National Health Surveillance and Research, Executive Vice-President, Statens Serum Institut
Moderator: Rick Kaufman, Partner, Foley & Lardner LLP

10:30 – 10:45 a.m.
Break

10:45 – 11:30 a.m.
Panel: The Microbiome - New Frontiers in Personalized Medicine
Panelists:
Jessica Richman, CEO, UBiome
Michael A. Fischbach, PhD, Assistant Professor, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco
Ann Reid, Director, American Academy of Microbiology
Moderator: Keith R. Yamamoto, PhD, Vice Chancellor for Research, UCSF

11:30 – 11:50 a.m.
Presentation: Genomic Testing in Oncology - Toward Truly Personalized Cancer Management
Daniel S. Grosu, MD, MBA, Chief Medical Officer, Diagnostics, Illumina Inc.
Introduced by: G. Steven Burrill, CEO, Burrill & Company

11:50 a.m. – 12:30 p.m.
Fireside Chat: Personalized Medicine for Chronic Disease Management
Stephen Hauser, Professor & Chair, UCSF Department of Neurology
Discussion with: Scott Johnson, President, CEO and Founder, Myelin Repair Foundation

12:30 p.m.
Meeting Wrap-Up
G. Steven Burrill, CEO, Burrill & Company

12:40 p.m.
Lunch